Sign inGet started

Brady James Aloysius

Insider CIK 1916987 · VRNA Director · XERS Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
XERS Xeris Biopharma Holdings, A Award deriv2026-06-042026-06-0532,996$6.15 $202.9K32,996SEC↗
XERS Xeris Biopharma Holdings, A Award2026-06-042026-06-0524,193— $0113,359SEC↗
XERS Xeris Biopharma Holdings, S Sale2026-03-302026-04-0110,834$5.54 $60.0K89,166SEC↗
VRNA Verona Pharma plc D To issuer deriv2025-10-072025-10-08288,000— $00SEC↗
VRNA Verona Pharma plc D To issuer deriv2025-10-072025-10-0896,000— $00SEC↗
VRNA Verona Pharma plc D To issuer deriv2025-10-072025-10-08240,000— $00SEC↗
VRNA Verona Pharma plc M Exercise deriv2025-10-072025-10-0872,000— $00SEC↗
VRNA Verona Pharma plc M Exercise2025-10-072025-10-0872,000— $072,000SEC↗
VRNA Verona Pharma plc D To issuer2025-10-072025-10-0872,000— $00SEC↗
VRNA Verona Pharma plc D To issuer2025-10-072025-10-0823,176— $00SEC↗
VRNA Verona Pharma plc M Exercise deriv2025-08-012025-08-0524,000— $072,000SEC↗
VRNA Verona Pharma plc S Sale2025-08-012025-08-05824$13.14 $10.8K23,176SEC↗
VRNA Verona Pharma plc M Exercise2025-08-012025-08-0524,000— $024,000SEC↗
VRNA Verona Pharma plc A Award deriv2025-04-252025-04-2996,000— $096,000SEC↗
XERS Xeris Biopharma Holdings, A Award2025-03-282025-03-28100,000— $0100,000SEC↗
VRNA Verona Pharma plc A Award deriv2024-04-292024-04-30240,000— $0240,000SEC↗
VRNA Verona Pharma plc A Award deriv2023-04-282023-04-2896,000— $096,000SEC↗
VRNA Verona Pharma plc A Award deriv2022-03-142022-03-16288,000— $0288,000SEC↗